CN110079623B - Method for detecting toxicity of acinetobacter baumannii - Google Patents

Method for detecting toxicity of acinetobacter baumannii Download PDF

Info

Publication number
CN110079623B
CN110079623B CN201910445920.7A CN201910445920A CN110079623B CN 110079623 B CN110079623 B CN 110079623B CN 201910445920 A CN201910445920 A CN 201910445920A CN 110079623 B CN110079623 B CN 110079623B
Authority
CN
China
Prior art keywords
acinetobacter baumannii
pcr
mul
solution
control tube
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201910445920.7A
Other languages
Chinese (zh)
Other versions
CN110079623A (en
Inventor
黄维
张敏
郑超
邹全明
章金勇
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shenzhen Peoples Hospital
Original Assignee
Shenzhen Peoples Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenzhen Peoples Hospital filed Critical Shenzhen Peoples Hospital
Priority to CN201910445920.7A priority Critical patent/CN110079623B/en
Publication of CN110079623A publication Critical patent/CN110079623A/en
Application granted granted Critical
Publication of CN110079623B publication Critical patent/CN110079623B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844Nucleic acid amplification reactions
    • C12Q1/686Polymerase chain reaction [PCR]
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/166Oligonucleotides used as internal standards, controls or normalisation probes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention relates to a detection method suitable for toxicity of acinetobacter baumannii, and belongs to the technical field of biological detection. Taking a section of specific sequence in the acinetobacter baumannii as a marker, wherein the specific sequence exists in a section of gene sequence comprising 19 open reading frames in the acinetobacter baumannii, and the section of gene sequence comprising the 19 open reading frames is specific to the acinetobacter baumannii with high toxicity; and then, a primer is designed by using a marker specific sequence, and finally, the qualitative detection of high toxicity or low toxicity of the acinetobacter baumannii is completed based on polymerase chain reaction, so that the problems that the acinetobacter baumannii detection method in the prior art can only identify the existence of the acinetobacter baumannii, can not accurately and qualitatively distinguish different toxicity of each strain and the like are solved, and the application values of the marker and the detection method for the toxicity of the acinetobacter baumannii are ensured.

Description

Detection method suitable for toxicity of acinetobacter baumannii
Technical Field
The invention relates to a method for detecting the toxicity of acinetobacter baumannii, in particular to a qualitative detection method for detecting the toxicity of the acinetobacter baumannii into high toxicity or low toxicity, belonging to the technical field of biological detection.
Background
Acinetobacter baumannii is a non-fermented gram-negative bacillus, widely exists in the nature and belongs to conditional pathogenic bacteria. The strain is an important pathogenic bacterium of hospital infection, mainly causes respiratory tract infection, and can also cause bacteremia, urinary system infection, secondary meningitis, operation site infection, ventilator-associated pneumonia and the like. Due to the increasing trend of the drug resistance rate of acinetobacter baumannii to common antibiotics (especially carbapenem antibiotics) year by year, the acinetobacter baumannii attracts the close attention of clinicians and microbiologists. Patients infected by acinetobacter baumannii are mostly old, critically ill, weak in body resistance and patients using broad-spectrum antibiotics for a long time.
The difference in virulence exists among various strains of the acinetobacter baumannii, the infection of the strains with high virulence often leads to high mortality of patients, and the existence of the acinetobacter baumannii can be clinically identified only at present through a biochemical reaction or a mass spectrometry technology, but the difference in virulence among the strains cannot be effectively distinguished, so that the reference value for clinicians is very limited.
The patent document with publication number CN105803041A and name of "a kit for staining capsules of acinetobacter baumannii and a detection method" is disclosed by the national intellectual property office in 2016, month 07 and 27, wherein the patent document discloses: the detection method comprises the following steps: the Acinetobacter baumannii, the Congo red dye solution and the adhesive are mixed and then pushed into a sheet, and the Acinetobacter baumannii capsule is dyed by a Congo red dyeing method. The patent document provides an acinetobacter baumannii capsule staining kit and a detection method, which can be used for quickly evaluating the toxicity of acinetobacter baumannii, are based on a staining method and belong to morphological detection.
Disclosure of Invention
The inventor finds in research that the genome of Acinetobacter baumannii with high toxicity contains a gene sequence comprising 19 open reading frames, the gene sequence contains a unique specific sequence, and a primer is designed by taking the specific sequence as a target (namely a target polynucleotide), so that based on the research result, the specific sequence is taken as a biomarker and is applied to a method for detecting the toxicity of the Acinetobacter baumannii.
The invention aims to overcome the defects of the prior art and provides a detection method suitable for the toxicity of acinetobacter baumannii. In the technical scheme, the specific sequence is used as a marker, a primer is designed by using the marker, and then qualitative detection of high toxicity and low toxicity of acinetobacter baumannii is completed based on polymerase chain reaction, so that the problems that only the existence of the acinetobacter baumannii can be identified, different toxicity of each strain cannot be distinguished accurately and qualitatively and the like in the acinetobacter baumannii detection method in the prior art are solved.
In order to achieve the technical purpose, the following technical scheme is proposed:
the application of a section of specific sequence in the acinetobacter baumannii as a biomarker in a method for detecting the high-toxicity acinetobacter baumannii, wherein the specific sequence exists in a section of gene sequence comprising 19 open reading frames in the acinetobacter baumannii; if the specific sequence is detected to be positive, the toxicity of the acinetobacter baumannii is judged to be high toxicity; otherwise, if the specific sequence is detected to be negative, the toxicity of the acinetobacter baumannii is judged to be low;
the gene sequence comprising 19 open reading frames is shown as SEQ ID NO. 1;
the specific sequence is shown as SEQ ID NO.2.
A detection method suitable for the toxicity of Acinetobacter baumannii comprises the following steps:
s1: taking at least four PCR tubes, respectively numbering the PCR tubes as a positive control tube, a negative control tube, an experimental tube and a blank control tube, and preparing a 20 mu L PCR amplification system; wherein the content of the first and second substances,
adding 15-18 uL PCR reaction solution, 0.5-1.5 uL upstream primer, 0.5-1.5 uL downstream primer and 1-2 uL positive control into the positive control tube;
adding 15-18 uL PCR reaction solution, 0.5-1.5 uL upstream primer, 0.5-1.5 uL downstream primer and 1-2 uL negative control into the negative control tube;
adding 15-18 uL PCR reaction solution, 0.5-1.5 uL upstream primer, 0.5-1.5 uL downstream primer and 1-2 uL acinetobacter baumannii sample to be detected into an experimental tube;
adding 15-18 uL PCR reaction solution, 0.5-1.5 uL upstream primer, 0.5-1.5 uL downstream primer and 1-2 uL sterilized water into a blank control tube;
s2: and (2) respectively centrifuging the PCR amplification system obtained in the step (S1) for 30S at the rotating speed of 3000rpm, and then placing the PCR amplification system in a PCR instrument for amplification, wherein the conditions of amplification reaction are as follows:
reacting for 3min at 94 ℃; then 35 cycles are carried out, wherein the reaction is carried out for 30s at 94 ℃, for 30s at 57-63 ℃ and for 30s at 72 ℃ in sequence; finally, reacting for 5min at 72 ℃, and then keeping at 4 ℃;
s3: and (3) products obtained after the amplification reaction in the step (S2) are subjected to electrophoresis respectively, whether a band appears at the position of 91bp is observed, and result analysis is carried out. If the product after the amplification reaction of the positive control tube has a corresponding strip, and the product after the amplification reaction of the negative control tube and the product after the amplification reaction of the blank control tube have no corresponding strip, the success of the experiment is judged, and then the result of the experiment sample is obtained;
if the product after the amplification reaction of the positive control tube does not have a band correspondingly, or the product after the amplification reaction of the negative control tube has a band correspondingly, or the product after the amplification reaction of the blank control tube has a band correspondingly, the experiment is judged to be unsuccessful, and the experiment needs to be repeated until the experiment is successful, so that the result of the experimental sample is obtained.
Further, in S1, the acinetobacter baumannii sample to be detected is obtained from: inoculating the Acinetobacter baumannii to be detected in a culture medium until the OD600nm of the culture is 0.6-0.8, and taking a culture solution as an Acinetobacter baumannii sample to be detected. Meanwhile, in the step S1, the acinetobacter baumannii sample to be detected in the acinetobacter baumannii culture solution is identified by biochemical reaction or mass spectrum, and the identification technology of the biochemical reaction or the mass spectrum is the existing mature technology; the inoculation, culture, bacteria concentration detection and the like are mature prior art, such as: refer to the laboratory Manual of clinical bacteriology, in rock, et al.
Further, the PCR reaction solution comprises heat-resistant DNA polymerase, tris (hydroxymethyl) aminomethane hydrochloride solution, magnesium chloride solution, potassium chloride solution, triton solution, formamide solution and deoxyribonucleoside triphosphate.
Further, in the 20 μ L PCR amplification system, the concentration of thermostable DNA polymerase is 5U/uL, the concentration of tris hydrochloride solution is 200mmol/L, the concentration of magnesium chloride solution is 20mmol/L, the concentration of potassium chloride solution is 500mmol/L, the volume ratio of triton solution is 0.2%, the volume ratio of formamide solution is 10%, and the concentration of deoxyribonucleoside triphosphate is 10mmol/L.
Further, the upstream primer sequence is as follows: 5 'TTGAGAAGCTAAATTATGGCTCG-3', and the downstream primer sequence is as follows: 5 'GATAGCACAGAATCCATAAAGGAA-3'.
Further, in the 20 muL PCR amplification system, the concentrations of the upstream primer and the downstream primer are both 0.5umol/L; the upstream primer and the downstream primer are used for amplifying a specific sequence SEQ ID NO.2.
Further, the positive control is clinical acinetobacter baumannii strain nucleic acid which contains biomarkers and has high lethality in animal experiments through whole genome sequencing.
Further, the negative control is clinical acinetobacter baumannii strain nucleic acid which does not contain biomarkers and is non-lethal in animal experiments through whole genome sequencing.
Further, the thermostable DNA polymerase is preferably Taq polymerase.
The PCR instrument is a well-established technology in the prior art, for example: dongsheng Longong ETC811.
The electrophoresis is a well-established technique in the prior art, such as: agarose gel electrophoresis.
In the technical scheme, when a PCR amplification system is prepared, the amounts of the PCR reaction solution correspondingly added into the positive control tube, the negative control tube, the experiment tube and the blank control tube are consistent, the amounts of the upstream primer correspondingly added into the positive control tube, the upstream primer correspondingly added into the negative control tube, the amounts of the downstream primer correspondingly added into the experiment tube and the blank control tube are consistent, and the amounts of the acinetobacter baumannii sample to be detected, the negative control tube, the upstream primer correspondingly added into the blank control tube and the sterile water correspondingly added into the blank control tube are consistent.
By adopting the technical scheme, the beneficial technical effects brought are as follows:
1) The invention takes a specific sequence in a gene sequence comprising 19 open reading frames as a marker, and then completes the qualitative detection of high toxicity or low toxicity of the acinetobacter baumannii based on polymerase chain reaction, so as to solve the problems that the acinetobacter baumannii detection method in the prior art can only identify the existence of the acinetobacter baumannii, can not distinguish different toxicity of each strain accurately and qualitatively, and the like;
2) The invention has reasonable design principle, easy result judgment and high accuracy. The inventor applies a comparative genomics method to screen a section of gene segment comprising 19 open reading frames from the genome of Acinetobacter baumannii with high toxicity, and the existence of the gene segment is related to the toxicity of the Acinetobacter baumannii, so a plurality of specific primers are designed based on the specific sequence in the gene segment, and primers with excellent amplification effect for amplifying target polynucleotides are screened out by optimization, namely, the primers are finally limited to an upstream primer and a downstream primer with smaller non-specific reaction, so as to ensure that the reaction of a PCR amplification system is smaller non-specific reaction; finally, the acinetobacter baumannii is qualitatively detected to be high-toxicity or low-toxicity by polymerase chain reaction, and has higher specificity;
3) In the detection method, a PCR amplification system is prepared, then amplification reaction is carried out, and small non-specific reaction is ensured under the conditions of specific temperature, specific time, specific cycle number and the like. Meanwhile, in the preparation of a PCR amplification system, the culture solution (sample) of acinetobacter baumannii to be detected is directly added into an experimental tube, so that the detection process is simple and quick, the qualitative detection of high toxicity or low toxicity of acinetobacter baumannii can be completed only by 1-2 h, the time consumption is short, and the applicability is strong;
4) In the detection method, the PCR reaction solution, the upstream primer, the downstream primer and the Acinetobacter baumannii culture solution are added in sequence, and the substances are added in the sequence due to the large volume difference of the solutions, so that the convenience and operability of the experiment are guaranteed; on the other hand, the solution with smaller volume is not easy to be added into an empty PCR tube, thereby causing false negative, and therefore, the detection accuracy of the acinetobacter baumannii with high toxicity and low toxicity is indirectly improved.
Drawings
FIG. 1 is a flow chart of the detection method of the present invention;
FIG. 2 shows the result of agarose gel electrophoresis of the amplified reaction product after the PCR reaction, wherein lane M: nucleic Acid (DNA) molecular weight standards (Marker); lane 1: the PCR amplification product of the negative control tube; lane 2: PCR amplification products of the positive control tube; lane 3: PCR amplification products of blank control tubes; lanes 4-9: PCR amplification products of the test tubes (samples);
FIG. 3 is a comparison of lethality of positive and negative samples of highly virulent A.baumannii biomarkers in C57BL/6 mice.
Detailed Description
In the following, the technical solutions in the embodiments of the present invention are clearly and completely described, and it is obvious that the described embodiments are only a part of the embodiments of the present invention, and not all embodiments. All other embodiments, which can be derived by a person skilled in the art from the embodiments given herein without making any creative effort, shall fall within the protection scope of the present invention.
In the following examples, the one clinical isolate corresponds to one case, such as: the 62 clinical isolates corresponded to 62 patients infected with Acinetobacter baumannii. And, the specific number of samples is set at the maximum capacity.
Example 1
A detection method suitable for the toxicity of Acinetobacter baumannii comprises the following steps:
s1: taking four PCR tubes, respectively numbering the four PCR tubes as a positive control tube, a negative control tube, an experimental tube and a blank control tube, and preparing a 20 uL PCR amplification system; wherein the content of the first and second substances,
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL positive control into a positive control tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL negative control into a negative control tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL Acinetobacter baumannii sample to be detected into an experimental tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL sterilized water into a blank control tube;
the sequence of the upstream primer is as follows: 5 'TTGAGAAGCTAAATTATGGCTCG-doped 3',
the downstream primer sequence is: 5 'GATAGCACAGAATCCATAAAGGAA-3';
s2: and (2) respectively centrifuging the PCR amplification system obtained in the step (S1) for 30S under the condition that the rotating speed is 3000rpm, and then placing the system in a PCR instrument for amplification, wherein the conditions of the amplification reaction are as follows:
reacting for 3min at 94 ℃; then 35 cycles are carried out, wherein the reaction comprises the steps of reacting for 30s at 94 ℃, reacting for 30s at 60 ℃ and reacting for 30s at 72 ℃ in sequence; finally, reacting for 5min at 72 ℃, and then keeping at 4 ℃;
s3: and (3) products after the amplification reaction in the step (S2) are subjected to electrophoresis respectively, whether a band appears at the position of 91bp is observed, and result analysis is carried out. If the product after the amplification reaction of the positive control tube has a corresponding strip, and the product after the amplification reaction of the negative control tube and the product after the amplification reaction of the blank control tube have no corresponding strip, the success of the experiment is judged, and then the result of the experiment sample is obtained;
if the product after the amplification reaction of the positive control tube does not have a band correspondingly, or the product after the amplification reaction of the negative control tube has a band correspondingly, or the product after the amplification reaction of the blank control tube has a band correspondingly, the experiment is judged to be unsuccessful, and the experiment needs to be repeated until the experiment is successful, so that the result of the experimental sample is obtained.
Example 2
On the basis of embodiment 1, the present embodiment is distinguished in that:
when a PCR amplification system is prepared in the step S1, six PCR tubes are taken and respectively numbered as a positive control tube (one), a negative control tube (one), an experimental tube (three) and a blank control tube (one); the PCR amplification system is 20 mu L, wherein,
adding 15uL PCR reaction solution, 1.5uL upstream primer, 1.5uL downstream primer and 2uL positive control into the positive control tube;
adding 15uL PCR reaction solution, 1.5uL upstream primer, 1.5uL downstream primer and 2uL negative control into the negative control tube;
adding 15uL PCR reaction solution, 1.5uL upstream primer, 1.5uL downstream primer and 2uL acinetobacter baumannii sample to be detected into an experimental tube;
adding 15uL of PCR reaction solution, 1.5uL of upstream primer, 1.5uL of downstream primer and 2uL of sterilized water into a blank control tube;
in the step S2, the amplification reaction is carried out for 3min at the temperature of 94 ℃; then 35 cycles, wherein the reaction comprises the steps of reacting for 30s at 94 ℃, reacting for 30s at 57 ℃ and reacting for 30s at 72 ℃ in sequence; finally, the reaction was carried out at 72 ℃ for 5min and then maintained at 4 ℃.
Example 3
On the basis of examples 1-2, the present example differs in that:
when a PCR amplification system is prepared in the step S1, eight PCR tubes are taken and respectively numbered as a positive control tube (one), a negative control tube (one), an experimental tube (five) and a blank control tube (one); the PCR amplification system is 20 mu L, wherein,
adding 18uL PCR reaction solution, 0.5uL upstream primer, 0.5uL downstream primer and 1uL positive control into the positive control tube;
adding 18uL PCR reaction solution, 0.5uL upstream primer, 0.5uL downstream primer and 1uL negative control into the negative control tube;
adding 18uL PCR reaction solution, 0.5uL upstream primer, 0.5uL downstream primer and 1uL Acinetobacter baumannii sample to be detected into an experimental tube;
adding 18uL PCR reaction solution, 0.5uL upstream primer, 0.5uL downstream primer and 1uL sterilized water into a blank control tube;
in the step S2, the amplification reaction is carried out for 3min at the temperature of 94 ℃; then 35 cycles, wherein the reaction comprises the steps of reacting for 30s at 94 ℃, reacting for 30s at 63 ℃ and reacting for 30s at 72 ℃ in sequence; finally, the reaction was carried out at 72 ℃ for 5min and then maintained at 4 ℃.
Example 4
On the basis of examples 1 to 3, the present example differs in that:
during the preparation of the PCR amplification system in the step S1, thirteen PCR tubes are taken and respectively numbered as a positive control tube (two), a negative control tube (two), an experimental tube (seven) and a blank control tube (two); the PCR amplification system is 20 mu L, wherein,
adding 17uL PCR reaction solution, 0.8uL upstream primer, 0.8uL downstream primer and 1.4uL positive control into a positive control tube;
adding 17uL PCR reaction solution, 0.8uL upstream primer, 0.8uL downstream primer and 1.4uL negative control into a negative control tube;
adding 17uL PCR reaction solution, 0.8uL upstream primer, 0.8uL downstream primer and 1.4uL Acinetobacter baumannii sample to be detected into an experimental tube;
adding 17uL PCR reaction solution, 0.8uL upstream primer, 0.8uL downstream primer and 1.4uL sterilized water into a blank control tube;
in the step S2, the amplification reaction is carried out for 3min at the temperature of 94 ℃; then 35 cycles, wherein the reaction comprises the steps of reacting for 30s at 94 ℃, reacting for 30s at 61 ℃ and reacting for 30s at 72 ℃ in sequence; finally, the reaction was carried out at 72 ℃ for 5min and then maintained at 4 ℃.
Example 5
On the basis of examples 1 to 4, further:
in S1, the acinetobacter baumannii sample to be detected is obtained from: inoculating the acinetobacter baumannii to be detected into a culture medium until the OD600nm of the culture is 0.6, and taking the culture solution as an acinetobacter baumannii sample to be detected. Meanwhile, in the step S1, the Acinetobacter baumannii sample to be detected in the Acinetobacter baumannii culture solution is identified by a biochemical reaction or a mass spectrum, and the identification technology of the biochemical reaction or the mass spectrum is the existing mature technology; the inoculation, culture, bacteria concentration detection and the like are mature prior art, such as: refer to the "laboratory Manual of clinical bacteriology, in rock, et al.
Example 6
On the basis of embodiment 5, the present embodiment is distinguished in that:
the OD600nm involved was 0.8.
Example 7
On the basis of examples 5 to 6, the present example differs in that:
the OD600nm involved was 0.7.
Example 8
On the basis of the examples 1-7, further:
in the 20 muL PCR amplification system, the PCR reaction solution comprises heat-resistant DNA polymerase with the concentration of 5U/uL, tris hydrochloride solution with the concentration of 200mmol/L, magnesium chloride solution with the concentration of 20mmol/L, potassium chloride solution with the concentration of 500mmol/L, triton solution with the volume ratio of 0.2%, formamide solution with the volume ratio of 10% and deoxyribonucleoside triphosphate with the concentration of 10mmol/L.
Example 9
On the basis of the embodiment 8, further:
in the 20 mu L PCR amplification system, the concentrations of the upstream primer and the downstream primer are both 0.5umol/L.
Example 10
On the basis of example 9, further:
the positive control is clinical acinetobacter baumannii strain nucleic acid which contains biomarkers and has high lethality rate in animal experiments and is determined by whole genome sequencing; the negative control is clinical acinetobacter baumannii strain nucleic acid which does not contain biomarkers and is non-lethal in animal experiments, and the nucleic acid is determined by whole genome sequencing;
the biomarker is a section of specific sequence in acinetobacter baumannii, the specific sequence exists in a section of gene sequence comprising 19 open reading frames in the acinetobacter baumannii, the gene sequence comprising the 19 open reading frames is shown as SEQ ID No.1, and the specific sequence is shown as SEQ ID No.2.
Example 11
On the basis of the embodiment 10, further:
the thermostable DNA polymerase includes Taq polymerase.
Example 12
The relevance of the biomarker and the high toxicity of acinetobacter baumannii is verified.
1. The whole genome sequences of acinetobacter baumannii with different virulence are compared by using Spine software, a gene sequence (shown as SEQ ID NO. 1) which is located on a chromosome and is specific to the acinetobacter baumannii with high virulence and comprises 19 open reading frames is screened, and a section of specific sequence in the gene sequence is taken as a marker;
2. comparing the whole genome sequence of 62 clinical isolates with a highly virulent acinetobacter baumannii marker sequence by using Parsnp software in a Harvest software package to judge whether a marker exists;
3. principle of design
The mortality rate of the high-toxicity acinetobacter baumannii marker positive sample is obviously higher than that of the negative sample (shown in the following table 1), and the result has statistical significance (chi-square test, p is less than 0.01).
Figure 832531DEST_PATH_IMAGE002
A specific sequence (shown as SEQ ID NO. 2) in a section of high-toxicity acinetobacter baumannii marker gene sequence is screened out by adopting a comparative genomics method, and a specific primer is designed according to the sequence. On the basis, a detection method suitable for the virulence of acinetobacter baumannii is provided (shown in figure 1).
4. Based on polymerase chain reaction, the detection method comprises the following steps:
1) Sampling
Inoculating the acinetobacter baumannii to be detected in a culture medium until the OD600nm of the culture is 0.7, and taking a culture solution as an acinetobacter baumannii sample to be detected;
2) Preparation of PCR amplification System
Taking nine PCR tubes, and numbering as a positive control tube (one), a negative control tube (one), an experimental tube (six) and a blank control tube (one) respectively; preparing a PCR amplification system of 20 muL, wherein,
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL positive control into a positive control tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL negative control into a negative control tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL Acinetobacter baumannii sample to be detected obtained in the step 1) into an experimental tube;
adding 17uL PCR reaction solution, 1uL upstream primer, 1uL downstream primer and 1uL sterile water into a blank control tube;
3) Amplification reaction
Centrifuging each PCR tube subjected to the PCR amplification system prepared in the step 2) for 30s at the rotating speed of 3000rpm, and then placing the tubes in a PCR instrument (Dongsheng Longe ETC 811) for amplification, wherein the conditions of the amplification reaction are shown in the following table 2;
Figure 156196DEST_PATH_IMAGE004
the PCR reaction solution comprises Taq polymerase, tris hydrochloride solution, magnesium chloride solution, potassium chloride solution, triton solution, formamide solution and deoxyribonucleoside triphosphate; in a 20 mu L PCR amplification system, the concentration of Taq polymerase is 5U/uL, the concentration of tris hydrochloride solution is 200mmol/L, the concentration of magnesium chloride solution is 20mmol/L, the concentration of potassium chloride solution is 500mmol/L, the volume ratio of triton solution is 0.2%, the volume ratio of formamide solution is 10%, and the concentration of deoxyribonucleoside triphosphate is 10mmol/L.
The sequence of the upstream primer is as follows: 5 'TTGAGAGCTAAATTATGGCTCG-containing 3', and the downstream primer sequence is: 5 'GATAGCACAGAATCCATAAAGGAA-3'; in a 20 mu L PCR amplification system, the concentrations of the upstream primer and the downstream primer are both 0.5umol/L.
5. Judgment and result analysis
After the PCR amplification reaction, each PCR reaction product was subjected to conventional agarose gel electrophoresis, and the band appearing at 91bp was positive (as shown in FIG. 2). In 62 Acinetobacter baumannii clinical isolates which are verified by whole genome sequencing, the sample results of the Acinetobacter baumannii markers with high toxicity are positive; the results of samples without the highly virulent acinetobacter baumannii marker were all negative.
6. Verification of correlation between detection positivity and virulence of high-virulence acinetobacter baumannii marker
And (3) verifying the toxicity of the positive sample of the acinetobacter baumannii marker with high toxicity by using an acinetobacter baumannii pneumonia infection model.
Specifically, 3 Acinetobacter baumannii biomarker positive samples and 4 Acinetobacter baumannii biomarker negative samples are randomly selected according to the proportion of 2.5 multiplied by 10 8 The survival rate of C57BL/6 mice infected with CFU for 6-8 weeks in trachea is observed after 7 days, and the results are shown in FIG. 3, which show that: the survival rate of the mice is 0 and the death rate is 100 percent after 2 days of infection by the positive sample of the biomarker; after 7 days of infection of the biomarker negative sample, the survival rate of the mice is 50 percent, the death rate is 50 percent, and meanwhile, the death rate has significant difference (p) through log-rank test<0.0001). And the obtained high-toxicity acinetobacter baumannii marker positive strain presents high mortality after infecting mice, which indicates that the toxicity of the strain is high.
Furthermore, the clinical isolated strain of acinetobacter baumannii from Anhui proves the application value of the marker, the primer and the detection method for qualitatively detecting the high toxicity of the acinetobacter baumannii. The results show that: the mortality rate of the high-toxicity acinetobacter baumannii marker positive sample is obviously higher than that of the negative sample (as shown in table 3), and the results have statistical significance (chi-square test, p < 0.01).
Figure 732671DEST_PATH_IMAGE006
In a first aspect, the present invention shows a gene sequence (shown in SEQ ID NO. 1) specific to highly virulent A.baumannii having 19 open reading frames;
the second aspect shows that a specific sequence (shown as SEQ ID NO. 2) in the gene sequence (shown as SEQ ID NO. 1) is a marker, and a specific primer is designed based on the specific sequence;
the third aspect shows a detection method suitable for the toxicity of acinetobacter baumannii, under the normal condition, the toxicity of acinetobacter baumannii is weaker, a clinician cannot accurately judge whether a patient uses antibiotics, and the method can quickly and accurately detect whether the acinetobacter baumannii has high toxicity or low toxicity, so that the technical scheme has important reference significance for making a treatment scheme of acinetobacter baumannii infected patients.
The above is only a general embodiment of the present invention, and it should be noted that, for those skilled in the art, several other methods and improvements can be developed without departing from highly virulent acinetobacter baumannii marker sequences, specific primers, etc., which are within the scope of the present invention.
Sequence listing
<110> Shenzhen citizen hospital
<120> detection method applicable to toxicity of acinetobacter baumannii
<130> 2019.5.24
<141> 2019-05-27
<160> 2
<170> SIPOSequenceListing 1.0
<210> 1
<211> 18813
<212> DNA
<213> Acinetobacter baumannii
<400> 1
atgtctacag atattcaatt aaatttaatt ggcagaacac aagagctttt tgttgatgat 60
attcaacaat ggaataataa gttaatcgaa attgtttcct catcgaagtt tttagtttta 120
ggtggggcgg ggtctattgg ccaagcagtt gttaaagaaa tttttaaacg taatcctaag 180
aaactacacg ttgttgatat ttcggaaaat aatctaacag aagttgttcg tgatattcgt 240
agctcgtttg gctatatcga tggtgatttc caaacatttg cactagatat tggctctgct 300
gagtatgatg catatattca gaatgatggt gattttgact acgttttaaa tctttctgct 360
ttgaagcatg tacgtagtga aaaagatcca tttacattaa tgcgaatgat tcatgtcaat 420
attttgaata ctgaaaaaac gattcagcag tctattgaaa aaggcgtgaa gaagtatttc 480
tgtgtttcaa cagataaagc tgctaaccct gtaaatatga tgggtggctc aaaacgtatt 540
atggaaatgt tccttatgcg tcaaagtcag catattgata tttccacggc tcgttttgcg 600
aatgttgcat tttcagatgg ttctttatta catggtttta atcaacgtat tcagaaaaac 660
cagccaattg ctgcgccaaa tgatattcgc cgttatttcg ttactccaaa agagtcaggt 720
gagttgtgcc tcatgtcttg tttactaggt gagaatagag atattttctt ccctaagctt 780
agcgagcact tacacctcat tacttttgct gatattgcag tcaaatatct taataacctt 840
ggatatgagc cgtatttgtg tgagtctgag gatgaagcgc gtagcttaat tcagactttg 900
ccaaaacaag gaaaatggcc ttgtttattt gctggaagca caactacggg tgagaaagat 960
tttgaagagt tctttaccga taatgaaact ttagatatgc aacgttttaa taatttaggt 1020
gttattaaaa acgaactaaa tgttgaagaa gacaagttgc atgtatttga agaaaaaatt 1080
catgcaatgc tttcaaataa gcagtggaat aaagaagaaa ttgttgatct atttaactat 1140
atgatgccta actttggaca caaagaaaca ggtttatatt tagatgggaa aatgtaatgg 1200
atacttctaa atttaatcag tttgtacgag atatttatca taccaataat tttattccat 1260
tacatgaacc tcgttttctt ggtaatgaaa agaaatatgt attagatacg attgatagta 1320
cttttgtctc tagtgttggt gcatatgtaa atgacttcga agcaaaagtt caacaattta 1380
caggttgtac taaagccatt gcgactgtta atggaacagc tgcattacat attgctcttt 1440
tactagctgg tgtaaagcgc gacgatattg taatcacgca agcgctgact tttgtcgcaa 1500
cctgtaatgc cttgtcttat attggtgcgg aaccattatt tattgatgtt tcattgaaga 1560
cactcggttt gtgcccaaag gcattagacg cttatttgca agaaaatgct tttattgatg 1620
accaaggtgt atgtaaacac aaagcaacta ataaacgtat ttctgcaatc gttccaatgc 1680
atacatttgg tcatcctgtt gaaattgatg agcttcaaca ggtcgtaacc aagtggaata 1740
ttgcattagt tgaagacgct gctgaaagtt taggttctta ctacaaaggt aaacataccg 1800
gaacttttgg tctagtttca acacttagct ttaacggaaa taaagtcatc actacaggcg 1860
gcggcggtat ggtcttgtgt caagatgagg aacttggcat aagagcgaag cacattacga 1920
caactgcaaa aataccgcat ccttatgagt tttatcatga tgaaaatggt tttaactacc 1980
gtttaccaaa tttgaatgct gccttaggtt gtgcacaaat ggaaggcttg gaaggtttcc 2040
ttgctaaaaa gcgtgattta gctcagcaat atcaagattt ctttaaagat agtgatattt 2100
catttgttgt ggaacctgaa gactgccgat ctaactattg gttaaatgcc attgtttgca 2160
aagataaagc ccaacgagat ttgattttgg atgaaaccaa ttcaaataag gtgatgactc 2220
gcccaatctg gactttaatg accagattgc caatgtacca aactgcatta caaggcgatt 2280
taactaactc attatggttg gaagaaagag ttgtaaatat tccaagttca gttcctctgg 2340
agtaataaga atgaaaaaaa tagccgtttt tacaggaact cgagctgaat atggtttgct 2400
gtattggtta atgcgagata ttcagcaaga tccagagcta gaattacaaa ttctagctac 2460
ggctatgcat tattcatctg agcacggtga aacttggaaa actattgttc aagatggttt 2520
cgaaattacc gaatcggtag aaatgctact gtcatctgat acatcgtccg ctgttgtgaa 2580
atcaatgggt gtgggcttac ttggatttgc agatgcattg aaacgtatgc aacctgattt 2640
attagttgtt ttgggtgatc gtttcgaagc tttggcagtg acgcaggctg ctttaatcat 2700
gcatattcct gttgcacatt tgcacggtgg tgaaatcact gaaggtgcat atgacgaatc 2760
aattcgtcat gcgatcacca aaatgtctaa tatccatttt gctgcagcag aagaatacaa 2820
aaaacgaatt attcagttag gcgagcaacc agaaaaagta tttaatgtcg gcgcactagg 2880
cttagatcat atccagcgta caacatttaa aaatattgca gaattgagtg aattatatga 2940
ttttgatttt tcaaaaccat attttctcat tacttatcat cctgaaacta atctactaga 3000
agaaaatgtt gcacctttat ttgatgcact taagcaaata aaagatgtca attttgtctt 3060
tagttatcca aatgcagata atggtaatac taacattgtg aaagcaatgc ttgatttaaa 3120
agcacagttg ccagatcgtg tattgcttgt aaagagtttt ggtattcaaa actatttaag 3180
tgttttgaaa aatgctttag caatggtggg taattcttca agtggtctat cagaagctcc 3240
agcattacag gtaccaacag taaatattgg tgatcgtcaa aaaggacgct tacgttgtga 3300
gtctatactt gatgttagat tagacgaaag tgaaatttta gaagcattgc aaaaagcaat 3360
taatttccca gacgatgaat tgagtaaagt tgttccacca ttagggttag gcaatacttc 3420
tcagaaaata attgaactta ttaaaacgac ggattttaaa aagaaggcac cattttatga 3480
tctttaatca agacgaaatt tatgtcattg cagaaattgg tgtaaatcat aatggctctg 3540
tagagttagc aaaagagctt attttaaaag ccaaagaatg cggtgcgaat gctgtcaaat 3600
ttcaaacatt taaagcagat agtttattat ctgatcaaac tgaaatggct gcatatcaaa 3660
aagaaaatac tagttctagt caaagccaat tagagcttgt aaaaagttta gagctcactt 3720
atgagcagac agaagaaata cagaaatttt gtgatgagca tcaaattact tttatttcaa 3780
cgccgtttga ctctgatagt ttgaagttct tggtgaatga gatcgatgta ccttacttga 3840
aagtatcatc tgctgatatt tcaaatttac cgtttctcta tgaaattgca tgttcaaaaa 3900
agcatgtcat tttatctaca ggaacagcta gcctaggtga tattgaacaa gcattatcag 3960
tatttgcttt tgttatcgat aagggaacgg aagttcgacc atctcagcag ttatttagag 4020
aagcttattc taaaatttca gtacgtaaac agttgaaaga acaggtttct atcttacact 4080
gtgtaactca atatccggca ttatttgaag aaagtaatct taaagccatt tcaaccttaa 4140
aaaatgtatt tgatttggca acagggtttt ctgatcatac gcttgatgaa tacgcggcgg 4200
ttattggtgt aagtcttggt gctcgcattt tcgaaaagca tattacatta gataaaacga 4260
tggctggccc agaccatgca gcatcaatgg aaccagatga atttaagcat tatgtcgaaa 4320
ttttgcataa aacatatgca gctttgggcg atggtattaa atttatgcta gagcaagaga 4380
gcgataacta ttacctagta cgtcgtagta ttgtggctaa aacagatatt gcggaagggg 4440
agctgttaac ctctgacaat gtcacaacaa aacgagcagg tcgcgtttgt ttagaaccaa 4500
ataagtattg ggatgttgtt ggtacaaaag caaaacgtag ctttaaaaag aacgatttta 4560
ttgaaattta aatgaaaaaa ctggcgattt ttggttcagg tggctttgca aaagagctag 4620
tagatttagc aatagatcaa ggctaccgcc atatattttt tttagaaaga aatgccaaag 4680
atggtgacac cctacttggc ttccccattt tgccagaatc agcaatatcg acattaacgg 4740
atacggtata tgcgataggt gttgctgatc caaagattcg taaaaaaata tatgaagctt 4800
atcccgattt accttatccc aatttgattc attctcaatc atcacttggc tatggcattc 4860
gagagttgct agaacatagt aaaggtgtgg taattgcggc tggagcgaga attacaaatt 4920
catgtcgttt tggtcatttt attatagtaa gttttaacag cacaattggg cacgactgta 4980
ttctagaaaa ctacgtttct gtcatgccag gtgttaatgt gtctggttgt attcatttga 5040
agcaaggcac ttacattgga acaaatgctg ctattttgcc gggcaaaagt ccagagcaat 5100
tgaaatattt aggtgaaaac tccgttatag gcgcgggtgc tgtggttgtg aaacatacgg 5160
aaccgaataa ggtctatatt ggatcacctg ctaaggaatt aagtcgtgac tagagatgtt 5220
aataatataa ttttgcataa aaatgattca attttgaaag cattagagct acttgattta 5280
tatgctttaa gaattgtttt ggtcgttgat gatcacaatc aattgatcgg aagtattaca 5340
gacggtgata ttcgtagagg gcttttaaaa ggccaagatg tgcatgcagc tgttgaaaca 5400
atcatgcata ctaaccctta tagtattgaa gaaggtagct taaataaccg ccagattttt 5460
gagatcatgc gtgaaaaaag ttatctggca ttaccagtaa ttaaaaataa tcagctagtt 5520
aatatcatta cgcttgatga tttgattcgt aaaaaacgta aagaaaatcc agtttttatt 5580
atggctggag gatttggaac acgtttacgt cctttaacag atacatgccc aaaaccaatg 5640
ttacctgttg gtggtaagcc tttactagaa accattatct caagctttaa aaatcaaggc 5700
ttttataaat tttatatttc tactcactat ttaccagaag tgattaatga gcattttggt 5760
aatggtgaga agtttgacgt acagattcaa tatgtacatg aaactgatcc gcttggaact 5820
ggcggtgcat tgagtttatt gccagcatca gatattaaat tgccattcat tgtgattaat 5880
ggtgatgtac taacaaacat gaattttgaa aaattattgg actttcatga aaagcgcgaa 5940
gctattgcaa cgatgtgcgt gagagaattc caatatcaaa ttccttatgg cgtagttaac 6000
tctgaagata atgtaataca aagcatgact gaaaaaccaa gttatttctt tgatattaat 6060
acaggtattt atgtcatttc ccctgaattg ttggcacaag ttaatgcaca gtttattggt 6120
atgccgacta tcttagaaca gcaaatggaa aagaaaaata aagtcttaag ctatccttta 6180
catgaatatt ggctcgacat cggtcatatg gaagactata accgtgcgca aaaagatatt 6240
catatgttgg gtctagaata atatgaaaaa tattgctgtt attggtttag gtaatattgc 6300
tacccgacat cgtcgtaacc ttaaaatgct ttttcctgaa gcaaaattaa ttgtgatgtc 6360
tgctagtggc cgtattccta aagagccagt gactgatagc gatcatatag cagaaagtgt 6420
tgatgaaatt attcagttgc aagttcagtt tgcaataatt gcctcaccag ctccttttca 6480
tgcccaacat gcactaccac ttattaaagc aggtatccct gtattaatag aaaaaccagt 6540
atcagttacc cagacagatg ctcaagcttt aattgatgca gaagcccagt ataagacacc 6600
tgtagcagta ggttactgtt tgcgctattt accttcagcg cagcaagtac gacaaatgat 6660
acaagagggt gtcattggaa acttatataa tgcatttatt gaaattggtc agtatttacc 6720
agattggcga cctaccaagg attatcgcga aacagtatct gctaaaactg aattgggggg 6780
aggagtccta ttagagctga gtcacgagtt agattatgct caatggattt taggttcgct 6840
tactcctaaa tatgtcgttt tacgtgcttc agaagagctc ggtttagaag tcgaggataa 6900
tgccgatctt ttaatgacaa cagcgaaagg agctgttgta aatatccact tagatttttt 6960
gcagcgtaaa gcacatcgta aatgtcgttt tattggcagt gaaggatgta ttgagtggga 7020
tttaattcga aatgaagttg tgcttattaa ggctaaagag caacaagaaa tttatagcgc 7080
ccctgagtgg gataaaaatc aaatgtattt agaaatggtt accgatttta ttaaaaaaat 7140
aaacggacag ccaaaccaat ctataagtct gcaagaagct gaaagaacag taggcctgat 7200
tgtagagatg aaagaatttg tgacgaaaga atgagactgc ttatatgaga aattttgcat 7260
ttatttttgc tagaggcggc tctaaaggtt tacctggaaa aaatattaaa ccattggcag 7320
gaaaaccgtt attacaatat tcaattgata ccgctttagc atcggatttg attgaacaag 7380
tttttgtttc aacagatgat caggctattg cacaagtcgc tatagaaggt ggagcaattc 7440
ttatagagcg acctgctgaa ctagcaactg atcaaagtcc agaatggttg tcttggcgtc 7500
atgcagttga gtgggcaact gagcactatg gctcatttga tgggtttgtt agtttacctg 7560
caactagtcc attacgtagc caagaggatg tagaggctgc gattttaaaa agacaagcag 7620
agacagctga tatttgtatt gcagttacac ccgcaagtcg cagtccttat ttcaatatgg 7680
ttaagtacaa tgaggctggt tttgttgagc ttgtcaatca gcctgaaggt gaagtatcac 7740
gccgtcaaga tgctcccaaa gtttttgata ttacaacagt agtttatgcg acaacgcctg 7800
agtttgtatt aaatagctat ggtttatttt cagggaaagt tgcgagtatt gaagtaccaa 7860
aagcaagagc tgtagatatt gatgatattt acgattttcg tttagctgaa gctattatta 7920
aaggtgaata attgatgcaa aatttattac agaataaaac ctttttagta gctggtgccg 7980
gtgggttatt aggcacgcgt ttagtggcgg ctatattaga acaaggtgca aaagttattg 8040
cagctgatat aaaccttgaa tctatggcaa ctcgattaag tagtgtagga gttaatacta 8100
caaacgaaaa gttatcgttg gtttccttag atgtaacaaa tgaaacaagt gtaaagttat 8160
ttttttcaac agatcttaaa attgatgggg ctgttaatac aacataccca cggaataaga 8220
cttatggttc gcattttttt gatgtgactc ttgaaagctt taatgagaac ttatcactac 8280
atttaggtag tatgtttttg tttactcagc aatgtgccaa atattttacg caataccaga 8340
ctcctttttc gcttgtaaat atctcatcta tttatggagt agtggctcca aaatttgata 8400
tttataacaa cacgaaaatg accatgcctg ttgagtatgc tgcaattaaa tcagcaacac 8460
tccatttaaa caaatacaca gttgcttatg tcaacgacag ccgattccgc attaattgtg 8520
taagtccagg tggtatcttt gatcatcaac ctgaaccatt tttagaagca tataagagcc 8580
atacccatgg agctggtatg ttagatgtta cagaaatcat aggttcagtt ttattcttac 8640
tttctgaaca atcaagatat gtaacaggtc aaaatattat tgtcgatgat ggcttttcaa 8700
tataacttaa ttatgagtaa tatatatata ggtgattggt aatatgaata ttattaataa 8760
tatagttgta aaattttttt taacaatagt tttttatata atattcctat taactttaga 8820
tatttttcct aataaacacc tttttgctat tttttcattt agtgtttatt tgttaaatag 8880
accaacattt attttatcac ctcggaatat gatatttata tattatttct tgtggtttgg 8940
tttggcacct atatttgcgg atagatataa ttatttagat tattctgata atatagttta 9000
taaatcttat gtttatttgt cttcaagttt tataactatg atattagttt ctatgtgtat 9060
agaaactaaa tacgaaaaaa agttttcttt tataaaagtt gattatagta atgtaagaat 9120
cgatggtaaa aaactaactt ttacttttat atttagtttt cttttttttc ttttgtattt 9180
atttaatact ggaggattta gttactggat agcaaatatt gatcgagctt ttttgactag 9240
gcaaggggca ggagtatact atttaggctt ttcattgttt ttccccgtat ttatattttt 9300
tactagattt aagtataaaa atttaatttt attaagtaca ttaagtttat tagtgatagc 9360
tttaagtcca tttataggta gtaaacaaaa aattatttat tgttttttat tactgttttc 9420
ttccttaatt ttgagaagaa agttgacact aagtaattct ttaatgattg gcttgcccac 9480
aatcttttta tttgtattag ggaattattt tagaaatgtt tcatggatga cattaagcga 9540
tgttgcttca tattcattta attattttga tactttagat tctttattgc tatttttata 9600
taacagacat tacccatttg aaattatgtc agtaggactc cctttaaata aaattgttaa 9660
tttatataca ggtggcgatg aattttttga tgtaagtgca tattatacta atatatactt 9720
tcctgatgct tggaatatac gagcaacagt acaatttcct gtggaagtag atttattttt 9780
aagttttggt ttttgggtgg gattaattcc tttaggaatt tttgttggaa tatattcatt 9840
aattttcatt aaaatgttat ctagtgaaaa aattgtatat ggttttatat ggtttaattt 9900
atttttctat ttgttaagtc acatgcgtgg tggattattt atttggacgg atttatattt 9960
atatccttat cttattttag tatattttct ttttaaagag gttaaagtta atgtgcctaa 10020
aaaataagaa atatgaaatt ataaaaaaag ctattgaaaa tgaaatttca gtagataatt 10080
atctttttga gaagctaaat tatggctcga aaaagctatc tattttcaaa atgctacgat 10140
tcaaagataa aattccttta tggatttctg tgctatcttc tattttaata ccaatttatt 10200
ttgctattga attttttgtt ttttttggaa ggagtagaaa tacatcaaat cttgaaaatg 10260
atcaatattt tttatctttt tctaactctc caaaagtaat tgcaatttat gaagaatatg 10320
cttctgatat agagtttttg caatgtatta ataataaagt ttattgtttt gttggctatt 10380
taagtcctct agttatcctg aagagtttta ttcattcaat tatactttac tttaaaatga 10440
tattttttgt taatattaaa tattatttac acttaacagc aatttttgaa ttaattttat 10500
tttatgaatt tgttattgta ttaaataaaa gaaatataaa taaaatatgt gtggtaaatc 10560
attatgatag gtggttaact gttttgtcaa atattggtaa ttttgatatt gagataatac 10620
agcatggaat tttaacagaa aattatgttg ttaagcataa aataccaaat atttcttttt 10680
taaaagtttt tgataaatct caattgagta tttttctaaa aaatatatta gagggtatac 10740
ctaataaaat tgattatatg aaaattagtt tagatatcaa cttttctgat aaatgtgaag 10800
tattgataat tagtaatcca ttttttataa atcaggaact gttattatat aaattcttga 10860
aagataaagg gattaaagtt ttttttagac ctcatccact ttatattaat gaagaaataa 10920
aaagtgtagt tgaaaatgat gagttatgtt taggaaaaag atttccatat cctaacgttt 10980
gcttatgtaa tgagtctact ttgggtaaag aatatgaagc aatgggtttt aaagtattat 11040
ggtggaatca aaatacagat tttcataaga tatggaattt agttaataat gcgtaatttt 11100
attttatatg gtttagcttc tgcttttaat agaggtggag tttttcttat actcccttta 11160
ctagctgctt tactttcagt tgtagattac ggtaaatttt ctctctatat gacagtagtt 11220
caacttttag tgccgctaat aagtctaaat atttctttat tggtgggtag ggaaatttac 11280
gaaaaaccta ttgtagttaa aagctttgtt gtactattta atagattttc tatttttaca 11340
ataatagttt tttttacttt aaattttttt attagaaata ttattttatt gattttaatt 11400
tatacctttt tggaagctat ttttttggtg aattctacat atattcgctt taagtatggt 11460
gcagatcaat ttttctatgt ttgttttttt aaaattttta ttctttcttt tttattagga 11520
agtttcttta tctatgataa gcagataata gtatcaataa aaaatcttat catgatcttt 11580
tctttttcta atttatcaat tgtatattat cttgtaaaga cctctttttc tttcagtttt 11640
aagagaatgt ttgtaattat aagcaactat aagagtatgc tacttttttc tattgggtta 11700
ttacctcata cactttctca atgggtaagt tcaagttcag accgtttttt tgtcaaactt 11760
tatacaaatg atatagaact agggtactac tcattttcat actctctggc tgctatattt 11820
atgattgtaa atagttcatt agctctcgga atacctcaat tatgtgttaa aaattttatt 11880
tattttaatt ccaaaaaatt ttactcaata ttcttttcac tagtgtcaat cttatgggtt 11940
ctatttttaa ttatttatat tgggatatta tattattttt cagacaagta tgatgttaaa 12000
tatatattta aaattggata tgtaattcta gtagggatgt attttttatc gttctattat 12060
tattattcgt cttttctttt ttatgataga gcatctaaaa agttatctta tattactttt 12120
tttgtggcag ttttaaatgt ttctctagta gtgcttctta ctcctttgtt tggtatacta 12180
ggtactgcct tcagtacatt aatatcctat ttaatatatg ttttaatgtc ctataaacat 12240
gcaagtgtta attatacggt aactaatttg tatgctcctt tatctttcat agtaattatt 12300
tcagtatcta tatttgtttt tttatacttc tttaaaatag gtggtgtgag ttatgtttaa 12360
aaataaggtt ttattaatta ctggtggtac aggatctttt ggaaatgctg tattaaaacg 12420
atttatagat agtgatttta aagaaatccg tatctttagt cgtgatgaaa aaaagcaaga 12480
tgatatgcgc aagaaatatc aatcagctaa gcttaaattt tatatagggg atgttcgaga 12540
ttttaattct gttttaaatg taactagagg tgttgattat atttttcatg ctgcagcact 12600
taagcaggtt ccttcttgcg aattttatcc aatggaagct gttaaaacaa atgtgttggg 12660
gacagaaaat ttattagaag cagccattca aaacaatgtt acaagggtag tttgcttaag 12720
cacagataaa gctgtatatc ctattaatgc aatgggcatt tctaaagcca tgatggaaaa 12780
agttatggtc gcaaagtcac gtaacctaga aggcttagat acagttattt gtggcactcg 12840
ttatggcaat gtgatggctt cccgtggttc tgtgattcca ttgtttgttg atcaaatacg 12900
tattggtaaa tctattacaa taacagatcc gaatatgaca cgttttatga tgactttgga 12960
agatgcggta gacttagttc tctatgcttt cgagcatggt gaaaacgggg atatttttgt 13020
acaaaaagca cctgcggcta ctattgatac tttagctaga gctattactc aattattaga 13080
taaacctgaa catccaattc atattattgg tactcgccat ggagaaaaag cttatgaggc 13140
tttattaagt cgtgaagaaa aagcatgtgc cgaagatctc ggtgattatt tccgtgtacc 13200
agcagaccaa cgcgacttga actacgaaaa gtatgtagaa gatggtgatt taaaaattac 13260
tgagttcgaa gattacaact cacataacac cactcgtcta gatgtagagg gtatgaaaca 13320
attattgctt aaactagatt ttgttcgcgc attaacaaga ggcgaatata tttcaccaga 13380
ggcgtaagca tgaaagtttt agttaccggt tctaatggtt ttattgcaaa aaactttatt 13440
cagtttttat cagagaaggc tgaagttgag attttaaaaa ctcatcgtga aacaacagat 13500
caagagttag agcaatcagt tcttgcttcg gactggattg tgcatttagc gggtgtgaat 13560
cgccctttaa atgaaagtga atttgcggaa ggcaatacca ctttaacaga aaagatcagt 13620
caaattttgc agcaagcaaa taagaaaaca cctgttatct tatcgtcttc tattcaggtc 13680
gagcgtgata acccctatgg taaaagtaag ctaggtggag agcaggcact ggtcactctt 13740
catcaagcag aaggtaatcc ggtttatatt tgccgtttag ccaacgtttt tggtaaatgg 13800
tcacgcccta attataactc tgcagttgca actttttgcc ataatgttgc aaatgatttg 13860
cccttacaaa ttcatgatga aaatgctgtg attcgtcttg tttatgtcga tgatgtagtt 13920
gaaacattct ggaatattct gaatgggcaa caagttgaac aaattttcca agtcgaacct 13980
gaatatcaaa ttaccgtagg tgatttggct aaagttttaa atggctttaa agcatcaaga 14040
gatacactta ttaccgaccg tgtgggaaca ggtcttactc gtgcacttta ttcaacttat 14100
ttgagttttt taaagcctga gcaattcgat tacagtgttc caaaatatgg tgatgctcgc 14160
ggtgtattcg ttgaaatgct gaaaacccca gatgcagggc aattttctta ctttactgct 14220
catccaggaa ttacccgtgg tggtcattat caccatacaa aaactgaaaa gttccttgtt 14280
attaagggta aggcattatt taagtttaag catgttgtaa caggtgaatt ttatgagctt 14340
gaaacacaag gcgatgaacc acgaattgta gaaacggtgc ctggttggac acatgatatt 14400
actaacatcg gtgatgatga gatggtggta atgctatggg caaatgaaat ttttgatcgt 14460
gataagccag atacttatgc gatgccaata acaaattaag agtatagatt tgtgaaaaag 14520
ttaaagttaa tgacagtggt gggcacacgt ccagaaatta tccgtttgtc ttgtgtaatg 14580
gctgcgtgtg atgaatattt tgaccatatt attgttcata ctggtcaaaa ctatgactat 14640
gaattgaatg aaattttctt tactgatttg ggtatccgta aacctgacca tttcttaaat 14700
gcagctggtg cgacaggtgc agaaacgatt ggtaatgtaa ttattgcggt tgataagatt 14760
ttagatgaag tgcaacctga agctttactt gttttagggg acacaaacag ttgtatggca 14820
gtattacctg caaaacgtcg taaaattcca actttccaca tggaagctgg aaaccgttgt 14880
tttgatatgc gagttcctga agaaattaac cgccgaattg tcgatcatac ggctgatatt 14940
aatttaactt acagtacgat tgcccgcgat tatttattgg cagaaggttt accagctgac 15000
ttagtaatca aaacgggtag tccaatgttt gaggtacttc accattacaa agcaaaaata 15060
gaagcttctg atgttcttga gcgtttaaat ttaaaagagc atgaatactt tattgttagt 15120
gctcatcgtg aagaaaacat taactcagat cagaacttct tagatttggt tgaaatgtta 15180
aatgcagttg cagagcgata tcagtaccct gtgattgtat cgacacatcc tcgtacgcgt 15240
aaacgtattg aagagttaaa tattgatttt catcctttga ttcaattatt aaaaccactc 15300
ggttttagtg actacaacaa gttacagctt tcagcaaaag cggcattgtc tgatagtgga 15360
acgattaacg aagaatcatc aatcttgaat ttccctgcac ttaatttgcg tcaagcacat 15420
gagcgtccag aaggaatgga agaagcggct gtaatgatgg taggtttgaa agccgaacgc 15480
attttacaag gtttggcaat tttagaaggt caaactagag gcgaaaatcg tcttttgcgt 15540
ttagttgaag actacagtat gccaaatgtg agtgaaaaag ttgtgcgtat cattatgagt 15600
tacacagatt atgtaaatcg agtgatttgg aagaagtatt gaggttaagg cagtgaagaa 15660
gaaggtctat ttaatcacgg aatattatca tccatatcaa aatacgacag gttacttgtt 15720
aggaaaattg tatgacacct tgaatgtaca aagtgatata gaccttgttc ttattgcaaa 15780
agaggataca aactgtcctc aacatgcaaa tgcacacttt attaaagcta aaaagccaaa 15840
taaggcaagt ttgtttaaaa gatttttata tgaactaatt atcgctttta gttttttaat 15900
gaagactttg caagtagtga aaaaggatag tatcgttttt acaggtacga ctcctatttt 15960
actgcttttt gttttattta ttattaaaaa gtttctaaat tttagatgga tattattagt 16020
ccatgatgta tttcccgaaa atttagcagc tgctaaaatt ttaaaaaaag atcatttttt 16080
atttaaaatc ttaaaaagct tatttgatag gatttatgca agtgctgatg aggtgattgt 16140
cattggcaaa gatatgaaag agttagtaca tcaaaaaacg catcaaagta acaatattac 16200
tgtagtgcag aattggattg actcatctga tattggtaca gagcctaaaa ctaataaccg 16260
aattttacaa gaattgaact ggttggatag tgaaactacg atttttcaat tcttcggtaa 16320
tattggtcgt gtacaaggcg tagaaaatat tctgcatgct attcagaaaa tgaaatatgc 16380
acatttggca aaattcattt ttattggtga tggtgcatat gttgctcgtc ttaaagagca 16440
aatacagtct ttgggatctc aaaatattct ttattatgga tctttagatc agaaagaaaa 16500
aacaactggt ttaaatgcgt gtgatgttgc attgattact ttggctgatg ggatgttagg 16560
tttaggggtt cctagtaaat cttatttttc tatggcggca gataagcctt tgctagcaat 16620
tatggatagg gagtcagaag tagcagatat gattaatact catcatatcg gttgggtagt 16680
cccacctaat aatgaagagg ctttggcaaa acaacttgat gaaattgtgt tagcaaaata 16740
ctgctatgca ttcaattcat caagagaagt attaaatgaa ttttattcag aaaaagtagc 16800
aatgagtaaa attctaaata ttattagaaa atttacttaa gaatttaatt tttaaaatga 16860
atatcttgat tacaggaagt agtggttttg ttggttcata cttatgtgaa tattttacga 16920
caatgccaga atatagtgtt ctggctcaaa ctcgtaaaaa tacacaaaag ttaagtaatg 16980
atataaagac tataactttt gatataaatg atgatctaac ttctttggac ttgagctcat 17040
tagatgtcat tgtgcattgt gctgggcgtg ctcatattat gaaggaagtt gaaagtgatc 17100
cactatctat ttatagaaaa gtaaatgtag aaggaacact gaatttagct aaaaaagcag 17160
ctaaagctgg tgtaaaatga tttatattta tgagtagtat taaagtaaat ggtgaagtga 17220
gtgatcaagt accttttact cctcatgata atattataaa tattaaagat ccttatggat 17280
tatcaaaata tgaagctgaa caatctctat taaatttagc gcaaaactcg atgatggagg 17340
tggtcattat tcgcccagct ttaatctatg ggccaaatgt taaggcaaat tttaaaagta 17400
tgatcaatct ggcggctaaa ggaattcctt tgcctgttgg atgcctcgat aataaaagaa 17460
gtatggtcag tatttataat ttaagcgatt tcattaatat ttgtttatca catcctttag 17520
caaaaaatca ggctttttta attagtgatc aagacgatat aacagttaaa gaattattta 17580
cgaagttagc taaagttcag ggtagaaatc ttattgctgt gcctatacct aaagtattaa 17640
ttaatttttt aactaaactt cttaataaga gtgctgtcgc ttcaagactt tgttctgtat 17700
tgatcgttga cacctcaaag aatatagaac tattaggatg gagagctcct tttagctttg 17760
atgagagctt aaaattgatg ttcaaaaagt aataggtttg atatgaatgt tattatatct 17820
ttcatcattc tttttcttat ttcttttgta ttaactttta gtgttcgaaa atatgcttta 17880
agaaaaaata ttattgattt acctaacttt agaagttcac atatgaagcc cacaccacgt 17940
ggtggtggag tagcaatagt gataagtgtt ctaatggctt tattatatag ctatatatct 18000
cagtttataa gtttgaatga ttttttcatt atagggggga gttgtttgct tattgctctc 18060
cttggttttt gtgatgatca tgctcatatc aattctatgt tgcgcttaag tattcatttt 18120
attactgcaa catttatcgt atttagttta aatggctttg cccaagtctc tgtttttaat 18180
aatttaaact taggtttttt taccaacatt cttgctattc tttttctggt ttggatgctt 18240
aatttatata actttatgga tggtattaat ggtattgcaa gtatcgaagc aatatcagtc 18300
ggactaagtc tagctttatt atacagttgg tatgacatca ataattttat attacttgca 18360
atcacttcta ttgtctgtgg ttttctcgta tggaattttc caaaagctaa aatctttatg 18420
ggagatgtag gtagtagttt tttaggtttt ttattcgcta tattagcttt atatgcttta 18480
aaaatagact ttaagttatt tctagcttgg atcatttgtc taggggtttt tatagtagat 18540
gcaaccttta caattataag gagaatacta agaggggaga aaatatatca agctcatcga 18600
agccacgctt atcaatacgc tgctaggtat tttgatagtc atacacccgt aactttagca 18660
gttttaatca ttaatcttat atggctctta ccttgtgcat tttttgtatt aaataaagca 18720
atttctccat tagtcggttt aataatcgca tattttcctt taataatttt agctatttat 18780
tttaatgcag gacagttaga acataaaact taa 18813
<210> 2
<211> 1086
<212> DNA
<213> Acinetobacter baumannii
<400> 2
atgtgcctaa aaaataagaa atatgaaatt ataaaaaaag ctattgaaaa tgaaatttca 60
gtagataatt atctttttga gaagctaaat tatggctcga aaaagctatc tattttcaaa 120
atgctacgat tcaaagataa aattccttta tggatttctg tgctatcttc tattttaata 180
ccaatttatt ttgctattga attttttgtt ttttttggaa ggagtagaaa tacatcaaat 240
cttgaaaatg atcaatattt tttatctttt tctaactctc caaaagtaat tgcaatttat 300
gaagaatatg cttctgatat agagtttttg caatgtatta ataataaagt ttattgtttt 360
gttggctatt taagtcctct agttatcctg aagagtttta ttcattcaat tatactttac 420
tttaaaatga tattttttgt taatattaaa tattatttac acttaacagc aatttttgaa 480
ttaattttat tttatgaatt tgttattgta ttaaataaaa gaaatataaa taaaatatgt 540
gtggtaaatc attatgatag gtggttaact gttttgtcaa atattggtaa ttttgatatt 600
gagataatac agcatggaat tttaacagaa aattatgttg ttaagcataa aataccaaat 660
atttcttttt taaaagtttt tgataaatct caattgagta tttttctaaa aaatatatta 720
gagggtatac ctaataaaat tgattatatg aaaattagtt tagatatcaa cttttctgat 780
aaatgtgaag tattgataat tagtaatcca ttttttataa atcaggaact gttattatat 840
aaattcttga aagataaagg gattaaagtt ttttttagac ctcatccact ttatattaat 900
gaagaaataa aaagtgtagt tgaaaatgat gagttatgtt taggaaaaag atttccatat 960
cctaacgttt gcttatgtaa tgagtctact ttgggtaaag aatatgaagc aatgggtttt 1020
aaagtattat ggtggaatca aaatacagat tttcataaga tatggaattt agttaataat 1080
gcgtaa 1086

Claims (7)

1. A non-diagnostic detection method suitable for the virulence of Acinetobacter baumannii, which is characterized by comprising the following steps:
s1: taking at least four PCR tubes, numbering the PCR tubes as a positive control tube, a negative control tube, an experiment tube and a blank control tube respectively, and preparing a 20 mu L PCR amplification system; wherein the content of the first and second substances,
adding 15-18 muL of PCR reaction solution, 0.5-1.5 muL of upstream primer, 0.5-1.5 muL of downstream primer and 1-2 muL of positive control into a positive control tube;
adding 15-18 muL PCR reaction solution, 0.5-1.5 muL upstream primer, 0.5-1.5 muL downstream primer and 1-2 muL negative control into a negative control tube;
adding 15-18 mu L of PCR reaction solution, 0.5-1.5 mu L of upstream primer, 0.5-1.5 mu L of downstream primer and 1-2 mu L of acinetobacter baumannii sample to be detected into an experimental tube;
adding 15-18 muL of PCR reaction solution, 0.5-1.5 muL of upstream primer, 0.5-1.5 muL of downstream primer and 1-2 muL of sterilized water into a blank control tube;
the sequence of the upstream primer is as follows: 5 'TTGAGAGCTAAATTATGGCTCG-containing 3',
the sequence of the downstream primer is as follows: 5 'GATAGCACAGAATCCATAAAGGAA-3';
s2: centrifuging the PCR amplification system obtained in the step S1 for 30S respectively under the condition that the rotating speed is 3000rpm, and then placing the system in a PCR instrument for amplification;
s3: respectively carrying out electrophoresis on products subjected to the amplification reaction in the step S2, observing whether a band appears at a position of 91bp correspondingly, and carrying out result analysis;
the positive control is clinical acinetobacter baumannii strain nucleic acid which contains biomarkers and has high lethality rate in animal experiments and is determined by whole genome sequencing; the negative control is clinical acinetobacter baumannii strain nucleic acid which does not contain biomarkers and is non-lethal in animal experiments, and the nucleic acid is determined by whole genome sequencing;
the biomarker is a section of specific sequence in acinetobacter baumannii, the specific sequence exists in a section of gene sequence comprising 19 open reading frames in the acinetobacter baumannii, the gene sequence comprising the 19 open reading frames is shown as SEQ ID No.1, and the specific sequence is shown as SEQ ID No.2.
2. The method for detecting acinetobacter baumannii virulence suitable for non-diagnostic purposes according to claim 1, wherein in S1, the acinetobacter baumannii sample to be detected has an OD600nm of 0.6-0.8.
3. The method for detecting the virulence of acinetobacter baumannii for non-diagnostic purposes according to claim 1, wherein the PCR reaction solution comprises thermostable DNA polymerase, tris hydrochloride solution, magnesium chloride solution, potassium chloride solution, triton solution, formamide solution, and deoxyribonucleoside triphosphates.
4. The non-diagnostic purpose detection method suitable for Acinetobacter baumannii virulence according to claim 3, characterized in that in the PCR amplification system, the concentration of thermostable DNA polymerase is 5U/μ L, the concentration of tris hydrochloride solution is 200mmol/L, the concentration of magnesium chloride solution is 20mmol/L, the concentration of potassium chloride solution is 500mmol/L, the volume ratio of triton solution is 0.2%, the volume ratio of formamide solution is 10%, and the concentration of deoxyribonucleoside triphosphate is 10mmol/L.
5. The non-diagnostic detection method for Acinetobacter baumannii virulence according to claim 1 or 4, wherein the concentration of the upstream primer and the concentration of the downstream primer are both 0.5 μmol/L in the PCR amplification system.
6. The method of claim 3 or 4, wherein said thermostable DNA polymerase comprises Taq polymerase.
7. The method of claim 1, wherein the amplification reaction is carried out under conditions selected from the group consisting of: reacting for 3min at 94 ℃; then 35 cycles are carried out, wherein the reaction is carried out for 30s at 94 ℃, for 30s at 57-63 ℃ and for 30s at 72 ℃ in sequence; finally, the reaction was carried out at 72 ℃ for 5min and then maintained at 4 ℃.
CN201910445920.7A 2019-05-27 2019-05-27 Method for detecting toxicity of acinetobacter baumannii Active CN110079623B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910445920.7A CN110079623B (en) 2019-05-27 2019-05-27 Method for detecting toxicity of acinetobacter baumannii

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910445920.7A CN110079623B (en) 2019-05-27 2019-05-27 Method for detecting toxicity of acinetobacter baumannii

Publications (2)

Publication Number Publication Date
CN110079623A CN110079623A (en) 2019-08-02
CN110079623B true CN110079623B (en) 2022-11-11

Family

ID=67422027

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910445920.7A Active CN110079623B (en) 2019-05-27 2019-05-27 Method for detecting toxicity of acinetobacter baumannii

Country Status (1)

Country Link
CN (1) CN110079623B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111876509A (en) * 2020-09-10 2020-11-03 广州医科大学附属第一医院(广州呼吸中心) PCR method for detecting high-toxicity acinetobacter baumannii

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059379A1 (en) * 2007-11-07 2009-05-14 Dynamic Microbials Limited Antimicrobial compositions, formulations and uses thereof
CN104877019A (en) * 2015-04-24 2015-09-02 中国人民解放军第三军医大学 Protein of acinetobacter baumannii hypothetical protein A1S_1523 as well as preparation method and application of protein
CN106434996A (en) * 2016-12-06 2017-02-22 湖南圣湘生物科技有限公司 Kit and method for detecting Acinetobacter baumannii DNA
WO2017160779A2 (en) * 2016-03-14 2017-09-21 The Translational Genomics Research Institute Methods and kits to identify klebsiella strains
CN107338315A (en) * 2017-08-15 2017-11-10 中国人民解放军总医院 Kit for 15 kinds of pneumonia pathogenic bacteria quick detections

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009059379A1 (en) * 2007-11-07 2009-05-14 Dynamic Microbials Limited Antimicrobial compositions, formulations and uses thereof
CN104877019A (en) * 2015-04-24 2015-09-02 中国人民解放军第三军医大学 Protein of acinetobacter baumannii hypothetical protein A1S_1523 as well as preparation method and application of protein
WO2017160779A2 (en) * 2016-03-14 2017-09-21 The Translational Genomics Research Institute Methods and kits to identify klebsiella strains
CN106434996A (en) * 2016-12-06 2017-02-22 湖南圣湘生物科技有限公司 Kit and method for detecting Acinetobacter baumannii DNA
CN107338315A (en) * 2017-08-15 2017-11-10 中国人民解放军总医院 Kit for 15 kinds of pneumonia pathogenic bacteria quick detections

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"Acinetobacter baumannii LAC-4,complete geneme,CP007712.1";Ou,H.Y. et al.;《GenBank》;20150311;第1-8页 *
"Complete genome sequence of hypervirulent and outbreak-associated Acinetobacter baumannii strain LAC-4:epidemiology, resistance genetic determinants and potential virulence factors";Hong-Yu Ou et al.;《SCIENTIFIC REPORTS》;20150302;第5卷(第8643期);摘要、表3、第6页右栏第1段和第8-10页 *
"鲍曼不动杆菌研究进展";缪应纯等;《山东化工》;20171231;第46卷(第23期);第49-51页 *

Also Published As

Publication number Publication date
CN110079623A (en) 2019-08-02

Similar Documents

Publication Publication Date Title
Tzanakaki et al. Simultaneous single-tube PCR assay for the detection of Neisseria meningitidis, Haemophilus influenzae type b and Streptococcus pneumoniae
CN105018489B (en) Differentiate brucella street strain and vaccine strain A19 and S2 kit
Kee et al. Detection of leptospiral DNA by PCR
CN105002173A (en) Kit for identifying Brucella S2 vaccine strain and wild strain
CN101113475A (en) Primer for detecting pathogenic microorganism and multiple PCR using the same
CN102947467A (en) Assays and kits for serotyping pseudomonas aeruginosa and oligonucleotide sequences useful in such methods and kits
CN113151610B (en) Central nervous system infection pathogen detection kit and application thereof
CN111020041B (en) 16 different serotype salmonella specific new molecular targets and rapid detection method thereof
CN110669852A (en) Kit for detecting high-toxicity non-mucus Klebsiella pneumoniae
CN105018628A (en) Kit for recognizing Brucella A19 vaccine strain and wild strain
US20110287965A1 (en) Methods and compositions to detect clostridium difficile
EP1795614B1 (en) Diagnostic method and products useful therein
CN102424862B (en) Genotyping chip for legionella pneumophila, and kit for detection of legionella pneumophila
CN110079623B (en) Method for detecting toxicity of acinetobacter baumannii
CN110157824B (en) Kit for detecting high-toxicity acinetobacter baumannii and use method thereof
CN103160587B (en) Genetic typing chip of 10 common pathogenic legionella and detection kit
CN109811073B (en) Primer for rapidly detecting streptococcus agalactiae and streptococcus iniae at early stage by double PCR (polymerase chain reaction) and application of primer
CA2775273A1 (en) Composition, method and kit for detecting bacteria by means of sequencing
CN104328206B (en) The LAMP detection method and its primer special of clostridium difficile binary toxin and test kit
CN103060447A (en) Primers, probes, a test kit and a test method for triple real-time fluorescence PCR detection of four bacteria
KR100984785B1 (en) Primer set and probe for detecting Salmonella typhimurium
WO2005030027A2 (en) Salmonella detection identification
CN108715897A (en) Aeromonas veronii detection primer, kit, detection method and its development approach based on specific sequence
Valsangiacomo et al. A nested polymerase chain reaction for the detection of Borrelia burgdorferi sensu lato based on a multiple sequence analysis of the hbb gene
CN107338301B (en) SNP molecular marker associated with upland cotton spinning uniformity index and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
EE01 Entry into force of recordation of patent licensing contract

Application publication date: 20190802

Assignee: Guangzhou Saimo Biotechnology Co.,Ltd.

Assignor: SHENZHEN PEOPLE'S Hospital

Contract record no.: X2024980005517

Denomination of invention: A detection method for the virulence of Acinetobacter baumannii

Granted publication date: 20221111

License type: Common License

Record date: 20240510